Should an abnormal heart rhythm detected by a smartwatch in otherwise healthy young adults be treated? Are the benefits of this new technology worth the risks? Where is the technology headed?
Answers to these and other vital questions will be debated during the Meet the Trialist of the Apple Heart Study on Tuesday at EHRA 2019, a scientific congress of the European Society of Cardiology (ESC) that starts tomorrow in Lisbon, Portugal.
The largest study of a smartwatch app for detection of irregular heart rhythms including atrial fibrillation was presented today.
Atrial fibrillation is the most common heart rhythm disorder (arrhythmia). It causes 20 to 30% of all strokes and increases the risk of dying prematurely. Symptoms include palpitations, shortness of breath, tiredness, and difficulty exercising. But some people have no symptoms at all.
Read more at European Society of Cardiology
Photo Credit: fancycrave1 via Pixabay